These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16109592)

  • 1. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone in the treatment of alcoholism: predicting response to naltrexone.
    Volpicelli JR; Clay KL; Watson NT; O'Brien CP
    J Clin Psychiatry; 1995; 56 Suppl 7():39-44. PubMed ID: 7673104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
    Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
    J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of naltrexone to treat ambulatory patients with alcohol dependence.
    Galarza NJ; Díaz Ramírez D; Guzmán F; Caballero JA; Martínez AJ
    Bol Asoc Med P R; 1997; 89(10-12):157-60. PubMed ID: 9577049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse.
    O'Malley SS
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():77-81. PubMed ID: 8737005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients.
    Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L
    Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naltrexone double blind placebo controlled study in Israel.
    Lerner A; Sigal M; Bacalu A; Shiff R; Burganski I; Gelkopf M
    Isr J Psychiatry Relat Sci; 1992; 29(1):36-43. PubMed ID: 1568861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone in the treatment of alcohol dependence.
    Volpicelli JR; Alterman AI; Hayashida M; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):876-80. PubMed ID: 1345133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?
    Rubio G; Ponce G; Rodriguez-Jiménez R; Jiménez-Arriero MA; Hoenicka J; Palomo T
    Alcohol Alcohol; 2005; 40(3):227-33. PubMed ID: 15797885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing topiramate with naltrexone in the treatment of alcohol dependence.
    Baltieri DA; Daró FR; Ribeiro PL; de Andrade AG
    Addiction; 2008 Dec; 103(12):2035-44. PubMed ID: 18855810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
    Galloway GP; Koch M; Cello R; Smith DE
    BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.